The ₹7,500 crore pharma major is one of the firms that has tied up with Russian Direct Investment Fund to manufacture COVID-19 vaccine Sputnik V in India. The Income Tax Department has detected “unaccounted” income of ₹550 crore and has seized over ₹142 crore cash after it recently raided Hyderabad-based Hetero pharmaceutical group, official sources … Read more
Drug major Abbott on Tuesday said it has launched room-temperature-stable, single-dose formulation of carbetocin in India to help in the prevention of postpartum haemorrhage (PPH). PPH refers to excessive blood loss of 500 ml or more after vaginal delivery and 1,000 ml or more after a caesarean procedure, within 24 hours of childbirth. Although preventable, … Read more
Abbott, one of the most admired healthcare global company is also one of the oldest in India. It was established in India in 1910. When I first read about it, I couldn’t believe it and hence thought of sharing. Also for ease of reference, Abbott originally an American Company was founded in 1888. i.e., 22 … Read more
After injectables and oral solid drugs, now pharmaceutical firms are focusing on coming up with re-purposed inhalation products for Covid-19. While drug major Lupin is working on a remdesivir powder for inhalation, Mumbai-based Glenmark has tied up with a Canadian Biotech firm for Nitric Oxide nasal spray that reduces Sars-CoV-2 viral load and thus transmission. … Read more
After receiving the patent for a particular molecule, according to a senior official. Markers Lab, the research and development arm of the IT company, is working on developing the drug. The company along with Reagene Biosciences has filed for the patent for a molecule that can be used to develop a drug against coronavirus. “We … Read more
Shreevar Kheruka (Managing Director of Borosil Limited) announces that in the event of an unfortunate demise of any employee due to Covid – the family will be given 2 years of salary; and the education of the children of the employee will be paid till graduation in India. The above policy was made applicable for … Read more
Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adultage groups in Phase 2 trial Adjuvanted recombinant COVID-19 vaccine candidate triggered strong neutralizing antibody responses in all adult age groups High immune response after a single dose in patients with prior infection shows strong booster potential Global Phase 3 study expected to … Read more